Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $21.7 million.

  • Ekso Bionics Holdings' Liabilities and Shareholders Equity fell 2584.14% to $21.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.8 million, marking a year-over-year decrease of 1339.38%. This contributed to the annual value of $26.7 million for FY2024, which is 783.59% down from last year.
  • According to the latest figures from Q3 2025, Ekso Bionics Holdings' Liabilities and Shareholders Equity is $21.7 million, which was down 2584.14% from $23.2 million recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Liabilities and Shareholders Equity ranged from a high of $56.5 million in Q1 2021 and a low of $21.7 million during Q3 2025
  • Over the past 5 years, Ekso Bionics Holdings' median Liabilities and Shareholders Equity value was $34.0 million (recorded in 2023), while the average stood at $36.3 million.
  • Per our database at Business Quant, Ekso Bionics Holdings' Liabilities and Shareholders Equity soared by 23347.5% in 2021 and then tumbled by 2930.1% in 2023.
  • Ekso Bionics Holdings' Liabilities and Shareholders Equity (Quarter) stood at $49.2 million in 2021, then decreased by 16.81% to $40.9 million in 2022, then fell by 29.3% to $28.9 million in 2023, then decreased by 7.84% to $26.7 million in 2024, then fell by 18.73% to $21.7 million in 2025.
  • Its Liabilities and Shareholders Equity was $21.7 million in Q3 2025, compared to $23.2 million in Q2 2025 and $27.3 million in Q1 2025.